Serum Mac-2 binding protein is a novel biomarker for chronic pancreatitis

Tomohiro Maekawa, Yoshihiro Kamada, Yusuke Ebisutani, Makiko Ueda, Tomoki Hata, Koichi Kawamoto, Shinji Takamatsu, Kayo Mizutani, Mayuka Shimomura, Tomoaki Sobajima, Hironobu Fujii, Kotarosumitomo Nakayama, Kimihiro Nishino, Makoto Yamada, Takashi Kumada, Toshifumi Ito, Hidetoshi Eguchi, Hiroaki Nagano, Eiji Miyoshi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

AIM: To determine the efficacy of Mac-2 binding protein (Mac-2bp) for diagnosis of chronic pancreatitis. METHODS: Fifty-nine healthy volunteers (HV), 162 patients with chronic pancreatitis (CP), and 94 patients with pancreatic ductal adenocarcinoma (PDAC) were enrolled in this study. We measured serum Mac-2bp using our developed enzyme-linked immunosorbent assay kit. Additional biochemical variables were measured using an automated analyzer (including aminotransferase, alanine aminotransferase, γ-glutamyltransferase, alkaline phosphatase, triglyceride, C-reactive protein, and amylase levels) or chemiluminescent enzyme immunoassay (carbohydrate antigen 19-9 and carcinoembryonic antigen). The ability of Mac-2bp to predict CP diagnosis accurately was assessed using receiver operating characteristic (ROC) analyses. RESULTS: Serum Mac-2bp levels were significantly increased in CP patients compared to HV (P < 0.0001) and PDAC patients (P < 0.0001). Area under the ROC curve values of Mac-2bp for the discrimination of CP from HV and PDAC were 0.727 and 0.784, respectively. Multivariate analyses demonstrated that serum Mac-2bp levels were independent determinants for CP diagnosis from HV and PDAC patients. Immunohistological staining showed that Mac-2bp was expressed faintly in the pancreas tissues of both CP and PDAC patients. Serum aspartate aminotransferase, alanine aminotransferase, γ-glutamyltransferase, alkaline phosphatase, and triglyceride levels were significantly higher in patients with CP or PDAC. Serum Mac-2bp levels were highly correlated with protein levels of alanine aminotransferase, γ-glutamyltransferase, and C-reactive protein, but not amylase, suggesting that the damaged liver produces Mac-2bp. CONCLUSION: Measurement of serum Mac-2bp may be a novel and useful biomarker for CP diagnosis as well as liver fibrosis in the general population.

Original languageEnglish
Pages (from-to)4403-4410
Number of pages8
JournalWorld Journal of Gastroenterology
Volume22
Issue number17
DOIs
Publication statusPublished - May 7 2016

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Fingerprint Dive into the research topics of 'Serum Mac-2 binding protein is a novel biomarker for chronic pancreatitis'. Together they form a unique fingerprint.

  • Cite this

    Maekawa, T., Kamada, Y., Ebisutani, Y., Ueda, M., Hata, T., Kawamoto, K., Takamatsu, S., Mizutani, K., Shimomura, M., Sobajima, T., Fujii, H., Nakayama, K., Nishino, K., Yamada, M., Kumada, T., Ito, T., Eguchi, H., Nagano, H., & Miyoshi, E. (2016). Serum Mac-2 binding protein is a novel biomarker for chronic pancreatitis. World Journal of Gastroenterology, 22(17), 4403-4410. https://doi.org/10.3748/wjg.v22.i17.4403